Grow Group's Ben Langley talks to Proactive London's Katie Pilbeam about their recent fundraise to scale-up existing UK operations and accelerate expansion across Europe.
He explains their plans to expand 'aggressively'. Langley talks through their three divisions which are Research and Development (based in the UK and Canada), Trading (import and exporting on an international scale) and then Pharma which is import, distribute and dispensing with their own Pharmacy in the UK.
He adds that education of healthcare professionals is also a service they offer 'to empower doctors to try and make those possible prescribing decisions'. Langley discusses the recent FCA announcement that UK licensed medical cannabis companies should be able to list on a UK stock exchange and its impact on his firm.